Oncopeptides AB (publ) (STO: ONCO)
Sweden
· Delayed Price · Currency is SEK 1.438
-0.012 (-0.83%)
Nov 19, 2024, 5:29 PM CET
Oncopeptides AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 250.01 | 173.41 | 344.52 | 362.19 | 840.26 | 926.19 | Upgrade
|
| Short-Term Investments | - | 0.03 | 0.35 | 2.11 | 12.23 | - | Upgrade
|
| Cash & Short-Term Investments | 250.01 | 173.44 | 344.86 | 364.3 | 852.48 | 926.19 | Upgrade
|
| Cash Growth | 7.03% | -49.71% | -5.34% | -57.27% | -7.96% | 146.58% | Upgrade
|
| Accounts Receivable | 34.82 | 2.19 | 0.67 | 11.87 | - | - | Upgrade
|
| Other Receivables | - | 15.68 | 16.25 | 24.01 | 11 | 6.98 | Upgrade
|
| Receivables | 34.82 | 17.87 | 16.92 | 35.89 | 11 | 6.98 | Upgrade
|
| Inventory | 4.51 | 2.43 | - | - | 8.67 | - | Upgrade
|
| Prepaid Expenses | - | 5.43 | 1.71 | 7.42 | 8.96 | 3.43 | Upgrade
|
| Other Current Assets | - | 3.73 | 0.54 | 4.76 | 13.69 | 34.3 | Upgrade
|
| Total Current Assets | 289.35 | 202.9 | 364.03 | 412.37 | 894.8 | 970.89 | Upgrade
|
| Property, Plant & Equipment | 29.07 | 34.63 | 20.44 | 24.74 | 38.33 | 17.19 | Upgrade
|
| Other Intangible Assets | - | - | - | 1.41 | 1.83 | 2.11 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 8.18 | 2.26 | Upgrade
|
| Other Long-Term Assets | 0.8 | 0.85 | 0.85 | 0.85 | 3.62 | 1.04 | Upgrade
|
| Total Assets | 319.21 | 238.38 | 385.32 | 439.38 | 946.76 | 993.49 | Upgrade
|
| Accounts Payable | 12.1 | 15.03 | 28.22 | 35.7 | 136.14 | 80.99 | Upgrade
|
| Accrued Expenses | - | 18.46 | 17.24 | 36.61 | 150.27 | 44.91 | Upgrade
|
| Current Portion of Leases | - | 5.13 | 6 | 10.99 | 12.43 | 6.65 | Upgrade
|
| Current Income Taxes Payable | - | 0.58 | 0.3 | 0.05 | 3.05 | 2.04 | Upgrade
|
| Current Unearned Revenue | - | 0.5 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 34.17 | 5.24 | 33.91 | 141.94 | 52.52 | 30.6 | Upgrade
|
| Total Current Liabilities | 46.28 | 44.93 | 85.67 | 225.29 | 354.4 | 165.18 | Upgrade
|
| Long-Term Debt | 117.16 | 106.49 | - | - | - | - | Upgrade
|
| Long-Term Leases | - | - | - | 3.21 | 6.93 | 8.24 | Upgrade
|
| Other Long-Term Liabilities | 20.12 | 30.18 | 5.36 | 0.01 | 8.53 | 23.05 | Upgrade
|
| Total Liabilities | 183.55 | 181.6 | 91.03 | 228.51 | 369.86 | 196.48 | Upgrade
|
| Common Stock | 23.91 | 10.51 | 10.48 | 8.37 | 7.55 | 6.16 | Upgrade
|
| Additional Paid-In Capital | - | 5,414 | 5,403 | 4,982 | 3,919 | 2,544 | Upgrade
|
| Retained Earnings | 111.75 | -5,366 | -5,116 | -4,778 | -3,348 | -1,753 | Upgrade
|
| Comprehensive Income & Other | - | -2.2 | -2.3 | -0.92 | -1.54 | 0 | Upgrade
|
| Shareholders' Equity | 135.66 | 56.78 | 294.29 | 210.87 | 576.9 | 797.01 | Upgrade
|
| Total Liabilities & Equity | 319.21 | 238.38 | 385.32 | 439.38 | 946.76 | 993.49 | Upgrade
|
| Total Debt | 117.16 | 111.62 | 6 | 14.19 | 19.36 | 14.9 | Upgrade
|
| Net Cash (Debt) | 132.85 | 61.82 | 338.86 | 350.11 | 833.13 | 911.29 | Upgrade
|
| Net Cash Growth | 5.76% | -81.76% | -3.21% | -57.98% | -8.58% | 142.61% | Upgrade
|
| Net Cash Per Share | 0.98 | 0.68 | 4.12 | 4.65 | 13.36 | 17.63 | Upgrade
|
| Filing Date Shares Outstanding | 215.19 | 94.6 | 94.31 | 75.29 | 67.94 | 55.41 | Upgrade
|
| Total Common Shares Outstanding | 215.19 | 94.6 | 94.31 | 75.29 | 67.94 | 55.41 | Upgrade
|
| Working Capital | 243.07 | 157.97 | 278.36 | 187.08 | 540.4 | 805.71 | Upgrade
|
| Book Value Per Share | 0.63 | 0.60 | 3.12 | 2.80 | 8.49 | 14.38 | Upgrade
|
| Tangible Book Value | 135.66 | 56.78 | 294.29 | 209.46 | 575.07 | 794.9 | Upgrade
|
| Tangible Book Value Per Share | 0.63 | 0.60 | 3.12 | 2.78 | 8.46 | 14.34 | Upgrade
|
| Machinery | - | 16.1 | 15.99 | 14.42 | 19.94 | 3.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.